Sign in

CIK 0001674416

  • Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
Operating
EIN
473173478
Phone
+1 617-315-4600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
  1. 4 Shares withheld for taxes Chief Executive Officer gave up 19,401 shares (to pay taxes)
  2. 4 Shares withheld for taxes General Counsel and Secretary gave up 3,234 shares (to pay taxes)
  3. 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $54.03 ($1,350,827)
  4. 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $54.81 ($1,370,191)
  5. 4 Shares withheld for taxes Chief Financial Officer gave up 1,111 shares (to pay taxes)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $64.61 ($1,615,160)
  10. 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $66.84 ($1,671,084)
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $75.91 ($1,897,747)
  16. 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $61.59 ($1,539,862)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 26 · 502 filings